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Abstract
Background: Although an “epidemic” of depression is frequently claimed, empirical evidence is inconsistent,
depending on country, study design and depression assessment. Little is known about changes in depression over
time in Germany, although health insurance companies report frequency increases. Here we examined time trends
in depression prevalence, severity and health-related correlates in the general population.
Methods: Data were obtained from the mental health module of the “German Health Interview and Examination
Survey for Adults” (2009–2012, n = 3265) and the mental health supplement of the “German National Health
Interview and Examination Survey 1998” (1997–1999, n = 4176), excluding respondents older than 65. 12-month
major depressive disorder (MDD), severity and symptoms were assessed based on the WHO Composite
International Diagnostic Interview. Health-related quality of life (SF-36), self-reported sick days or days with
limitations in normal daily life activities were examined, too. Calculations were carried out population-weighted.
Additional age-standardized analyses were conducted to account for demographic changes.
Results: Overall, MDD 12-month prevalence remained stable at 7.4%. Women showed a shifted age distribution
with increased prevalence at younger ages, and increasing MDD severity. Time trends in health-related correlates
occurred both in participants with and without MDD. Mental health disability increased over time, particularly
among men with MDD, reflected by the mental component score of the SF-36 and days with activity limitation
due to mental health problems. Demographic changes had a marginal impact on the time trends.
Conclusions: In contrast to the ongoing international debate regarding increased depression rates in western
countries, we found no increase in overall MDD prevalence in Germany over a long period. In conclusion, increased
depression frequencies in national health insurance data and growing health care costs associated with depression
are not attributable to overall prevalence changes at a population level. However, shifted age distribution and
increased severity among women may reflect a rising depression risk within this specific subgroup, and changes in
health-related correlates indicate a growing mental health care need for depression, particularly among men.
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Background
An “epidemic” of depression as a disease of modernity
has been frequently claimed [1–3]. Given the high preva-
lence and enormous personal and economic disease
burden, this discourse highlights a global core health
challenge of the 21st century [4–6].
According to the World Health Organization (WHO),
over 300 million people were estimated to be affected by
depression globally in 2015, an increase of 18.4% since
2005 [7]. However, changes were mainly attributable to
the overall growth of the global population and its chan-
ging age structure [7, 8]. Likewise, a meta-analysis of
116 epidemiological studies revealed no change in the
prevalence of major depressive disorder (MDD) between
1990 and 2010 using age-adjusted estimates, challenging
the notion of an epidemic [3]. However, the empirical
evidence is inconsistent, depending on country, study
design, disorder definition and assessment of depression,
and several previous studies also indicate a slight in-
crease of depressive symptoms over time [9–12]. The
evaluation of time trends based on direct comparisons
of population-based data is difficult, and different de-
pression measures lead to varying results [1]. Even if
assessed with a fully-structured clinical diagnostic inter-
view based on diagnostic criteria of the Diagnostic and
Statistical Manual of Mental Disorders (DSM), the “gold
standard” for estimating depression prevalence [13, 14],
prevalence estimates are affected by minor changes in
the diagnostic criteria and revisions of clinical interviews
or diagnostic algorithms used in mental health survey
replications [15]. Thus, there is little agreement about
whether depression prevalence is increasing over time or
not. However, there is no evidence for a reduction in
prevalence [16, 17].
In Germany, little is currently known about changes in
depression prevalence over time. However, health insur-
ance companies have reported an increasing depression
frequency [18], and health care costs attributable to de-
pression have increased considerably [19]. Besides the
possibility of increasing depression prevalence in the
general population, time trends in health insurance data
could also reflect a rising need for mental health care
(e.g., due to increasing functional disability). Therefore,
the current study sought to examine changes over a
period of 13 years for MDD prevalence, severity, symp-
toms, and health-related correlates for the general popu-
lation in Germany.
Methods
Study design and population
Mental disorders, including MDD, were assessed in the
mental health module of the first wave of the “German
Health Interview and Examination Survey for Adults”
(DEGS1-MH, data collection 2009–2012, age range 18–
79 years) and the mental health supplement of its prede-
cessor, the “German National Health Interview and
Examination Survey 1998” (GHS-MHS, data collection
1997–1999, age range 18–65 years). Both surveys were
part of the German health monitoring system at the Rob-
ert Koch-Institute. They provide representative nation-
wide data about the health of the non-institutionalized
adult population in Germany. Design and methods are de-
scribed in detail elsewhere [20–24]. In brief, the core sur-
veys GHS and DEGS1 were conducted using two-stage
clustered random sampling (step 1: random selection of
study locations from all municipal communities; step 2:
random selection of participants from population-registries
in each selected study location). The net samples of GHS
(n = 7124, response rate: 61%) and DEGS1 (n = 7115, in-
cluding 3959 participants who participated in both surveys,
response rates: 64% among former GHS participants and
42% for newly sampled individuals) enable representative
cross-sectional and trend analyses [25]. The mental health
assessment was completed by n = 4181 participants in
GHS (conditional response rate: 87.6%, see [23]) and
n = 4483 participants in DEGS1 (conditional response
rate: 88.2%, see [24]). Excluding participants with
missing data regarding 12-month MDD from both sur-
veys and participants older than 65 from DEGS1-MH,
the final study sample was n = 4176 for GHS-MHS
and n = 3265 for DEGS1-MH.
Assessment of depression
Major depressive disorder (MDD) during the last 12
months was assessed by trained interviewers based on
the WHO Composite International Diagnostic Interview
(CIDI). The CIDI is a standardized fully-structured
computer-assisted clinical face-to-face interview. It is
widely used internationally in the assessment of mental
disorders according to the diagnostic criteria of the
DSM [13, 26, 27]. A modified German version of the
CIDI, the Munich Composite International Diagnostic
Interview, was used in the GHS-MHS (DIA-X/M-CIDI;
[28]) and modified for DEGS1-MH (DEGS-CIDI; [24])
to assess mental disorders, according to the diagnostic
criteria of the DSM-IV and DSM-IV-TR, respectively
[29]. MDD requires the persistence of at least five of
nine depression symptoms on nearly every day for 2
weeks or longer, of which at least one is depressed mood
or decreased interest/pleasure (DSM criterion A). Fur-
thermore, clinically significant distress and impairment
associated with these symptoms are necessary (DSM
criterion C). MDD exclusion criteria include lifetime
manic/hypomanic episodes and depressive symptoms
solely attributable to the direct physiological effects of a
substance, a general medical condition or attributable to
grief. The questions related to depression assessment
were similar in the versions of the CIDI in both the
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GHS-MHS and DEGS1-MH. However, skip rules, and
diagnostic algorithms for deduction of 12-month MDD
diagnosis differed slightly. Therefore, trend analyses were
based on a specific unified diagnostic algorithm. In brief,
the algorithm for 12-month MDD was limited to infor-
mation about the last 12 months without considering
lifetime information on symptoms and disorders, and
the operationalization of exclusion criteria was harmo-
nized between DEGS1-MH and GHS-MHS. This modi-
fied algorithm enables the estimation of prevalence
changes over time but also leads to slightly different esti-
mates compared with previously published MDD preva-
lence data for Germany [30–32]. For participants with
12-month MDD, depression severity was categorized
based on the number of depression symptoms into
“mild” (5 symptoms), “moderate” (6–7 symptoms) and
“severe” (8–9 symptoms) (see [33]).
Other measures
In the core surveys (GHS and DEGS1), socio-demographic
variables were assessed, including sex, marital status (mar-
ried and living with partner, married and not living with
partner, single, divorced, widowed), socio-economic status
(SES; classified in low, middle and high based on informa-
tion on education, occupational, status and net household
income, see [34]) and community size [categorized in rural
(< 5000 inhabitants), small town (5000 to < 20,000),
mid-sized town (20,000 to < 100,000) and large town, see
[25]. Age was assessed in years at the time of mental
health assessment (GHS-MHS and DEGS1-MH) and cate-
gorized into age groups (18–34, 35–49 and 50–65).
Self-rated health and health-related quality of life
(past 4 weeks) were assessed with a self-administered
questionnaire using the German version of the Short
Form 36 (SF-36) version 1 in the GHS [35, 36] and
version 2 in the DEGS1 [37, 38]. The first question in
the SF-36 (identical in both versions) measuring
self-rated health was dichotomized into poor/fair vs.
good/very good/excellent (see [39]). The SF-36 distin-
guishes eight domains for health-related quality of
life: physical functioning, role physical, bodily pain,
general health, vitality, social functioning, role emo-
tional and mental health. A physical component score
(PCS) and a mental component score (MCS) are con-
structed as total scales. “Norm-based scoring” enabled
comparability between SF-36 versions (see [37]).
Thus, SF-36 scales of both versions were standardized
to the 1998 American normative random sample then
transformed to an average value of 50 and a standard devi-
ation of 10. Higher values indicate better health-related
quality of life.
The number of days with limitations in normal daily
life activities due to mental or physical health problems
(past 4 weeks) were assessed in the same way in both
survey mental health modules [23, 24]: participants were
asked on how many days during the past 4 weeks they
were totally limited in daily life activities due to mental
and physical health problems. In this study, answers
were dichotomized into “no” vs. “any” days with limita-
tion. The number of sick days (past 12 months) was
assessed in an identical way in both survey mental health
modules using a self-administered questionnaire [21, 40]
and dichotomized into “no” vs. “any” sick days for this
study.
Statistical analysis
All statistical analyses were performed using survey-specific
weighting factors adjusting the study samples to the
demographic-geographic distribution of the population in
Germany, as on 12/31/1997 (for GHS-MHS) and 12/31/
2010 (for DEGS-MH). Adjustment took sex, age, educa-
tional status, federal state, and nationality into account, as
well as the probability of re-participation in the mental
health module subsequent to the core survey [23–25]. Stat-
istical analyses were performed using Stata 14.1 and survey
design procedures accounting for clustering and weighting.
Statistical significance was based on a two-sided signifi-
cance level of 0.05. Analyses were not adjusted for multiple
testing. Prevalence, frequencies, means and 95% confidence
intervals (95%-CI) for all measures were reported for each
sex for participants aged 18–65 years in the GHS-MHS and
DEGS1-MH. In addition, estimates from age-standardized
analyses were reported where appropriate. Note that the
provided age-standardized values cannot be interpreted as
valid cross-sectional population estimates themselves,
but reflect changes over time that are unaffected by
demographic changes in the underlying population.
To calculate age-standardized prevalence estimates,
participants from the GHS-MHS were weighted to
the demographic-geographic population structure
underlying the DEGS1-MH (as on 12/31/2010).
Distribution of depression severity and prevalence of de-
pression symptoms were reported for cases with 12-month
MDD. The Rao-Scott chi-square test was used to test time
trends. Age-adjusted results are described for depression
severity based on multinomial logistic regression model
with depression severity as dependent variable including
time point (GHS-MHS vs. DEGS1-MH) and age as inde-
pendent variables (reference: 1997–1999). Health-related
correlates are reported for participants with and without
12-month MDD to enable evaluation of time trends for
MDD cases compared with the remaining population. The
number of sick days was examined if participants reported
any sick days. Effect estimates for time trends were calcu-
lated based on linear, logistic and negative binomial regres-
sion models, including MDD, time point (GHS-MHS vs.
DEGS1-MH) and the interaction between MDD and time
point as independent variables (reference: 1997–1999).
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Results of additional age-adjusted regression models are
supplementary and described only if divergent from un-
adjusted results.
Results
Demographic features of GHS-MHS and DEGS1-MH
are shown in Table 1. Overall, the sample characteristics
showed little change in the underlying population be-
tween 1997–1999 and 2009–2012 regarding the
included variables, except for age distribution (shift to-
wards older age) and marital status (being married and
living with a partner became less frequent, while the
proportion of singles increased).
12-month prevalence of MDD
Overall 12-month MDD prevalence was stable over time
(GHS-MHS: 7.4%, 95%-CI: 6.5–8.5 vs. DEGS1-MH: 7.4%,
95%-CI: 6.1–8.8; p = 0.93 when testing for differences), as
well as age-standardized prevalence (GHS-MHS: 7.4%,
95%-CI: 6.4–8.6 vs. DEGS1-MH: 7.4%, 95%-CI: 6.1–8.8;
p = 0.96). Although prevalence estimates slightly increased
in women and decreased in men, these changes were not
statistically significant (see Fig. 1). This was also the case
with age-standardization (women: GHS-MHS: 9.6%,
95%-CI: 8.0–11.5 vs. DEGS1-MH: 10.5%, 95%-CI: 8.6–
12.8; p = 0.53; men: GHS-MHS: 5.2%, 95%-CI: 4.1–6.5
vs. DEGS1-MH: 4.2%, 95%-CI: 3.3–5.4; p = 0.22).
There were no significant sex differences regarding
prevalence trends (logistic model with MDD as dependent
variable, p = 0.30 for testing the interaction between sex
and time point, resp. 0.13 with age-standardization).
Prevalence among women was significantly higher than
among men at both time points.
There were significant age-specific time trends for
women (see Table 2): 12-month prevalence of MDD
increased in women aged 18 to 34 years (p = 0.005) from
8.8% (95%-CI: 6.6–11.6) to 15.6% (95%-CI: 11.3–21.0) and
decreased in the oldest age group (p = 0.002) from 9.8%
(95%-CI: 7.3–13.0) to 5.0% (95%-CI: 3.5–7.1). In contrast,
for women aged 35 to 49 years the prevalence remained
constant, at approximately 11%. For men, prevalence
estimates did not significantly differ within age groups.
There were also no significant changes over time
depending on socioeconomic status for men and women.










Age group (years), % (95%-CI)
18–34 36.4 (33.5–39.5) 30.0 (26.9–33.2) 35.4 (33.0–37.9) 31.3 (28.8–34.0)
35–49 34.0 (31.4–36.7) 36.0 (33.1–39.0) 33.3 (31.0–35.8) 36.1 (33.4–39.0)
50–65 29.6 (27.0–32.3) 34.0 (31.3–36.9) 31.3 (29.3–33.4) 32.5 (30.0–35.2)
Socioeconomic status3, % (95%-CI)
Low 17.0 (14.7–19.6) 18.2 (15.4–21.3) 17.6 (15.4–20.1) 16.9 (14.5–19.6)
Medium 61.4 (58.8–63.9) 58.3 (54.9–61.6) 62.9 (60.4–65.4) 63.1 (59.5–66.6)
High 21.7 (19.1–24.5) 23.5 (20.8–26.5) 19.4 (17.2–21.9) 20.0 (17.6–22.6)
Community size4, % (95%-CI)
Rural (< 5000 inhabitants) 20.8 (14.0–29.8) 15.9 (10.6–23.2) 18.9 (12.6–27.4) 14.5 (9.4–21.5)
Small town (5000 to < 20,000) 21.9 (14.7–31.5) 23.8 (17.4–31.7) 19.9 (13.3–28.5) 24.0 (17.6–31.8)
Mid-sized town (20,000 to < 100,000) 26.7 (19.1–36.0) 29.2 (22.1–37.6) 28.7 (20.7–38.3) 29.8 (22.7–37.9)
Large town (≥ 100,000) 30.6 (22.5–40.1) 31.0 (23.8–39.3) 32.6 (24.1–42.4) 31.8 (24.5–40.1)
Marital status, % (95%-CI)
Married and living with partner 63.3 (60.2–66.2) 57.9 (54.4–61.2) 65.3 (62.2–68.3) 59.2 (55.8–62.4)
Married and not living with partner 1.9 (1.2–3.0) 1.7 (1.0–3.0) 2.9 (2.1–3.9) 2.5 (1.6–3.7)
Single (never been married) 28.9 (26.3–31.7) 34.3 (31.2–37.6) 20.7 (18.5–23.0) 28.1 (25.3–31.0)
Divorced 4.9 (3.9–6.3) 5.2 (3.9–6.9) 6.7 (5.4–8.3) 6.9 (5.6–8.6)
Widowed 1.0 (0.6–1.6) 0.9 (0.4–1.9) 4.4 (3.4–5.7) 3.4 (2.5–4.7)
1German National Health Interview and Examination Survey 1998, mental health supplement (GHS-MHS, 1997–1999): weighted for population structure as of 12/
31/1997; age range: 18–65; n = 4176 with full mood disorders section within the Composite International Diagnostic Interview (CIDI)
2German Health Interview and Examination Survey for Adults, mental health module (DEGS1-MH, 2009–2012): weighted for population structure as of 12/31/2010;
age range: 18–65; n = 3265 with full mood disorders section within the Composite International Diagnostic Interview (CIDI)
3Based on information regarding education, occupational status and net household income
4GHS-MHS: community size as of 12/31/1996; DEGS1-MH: community size as of 12/31/2006
Bretschneider et al. BMC Psychiatry          (2018) 18:394 Page 4 of 13
Further analyses revealed similar significant differ-
ences and comparable prevalence estimates within age
groups, and, with regard to socioeconomic status,
when controlling for sociodemographic variables
(logistic models adjusting for socioeconomic status, or
age, as well as community size and marital status; re-
sults not shown).
Distribution of depression severity and depression
symptoms in cases with 12-month MDD
Overall, for men and women with 12-month MDD, mod-
erate severity was most frequent (> 40% at both time
points). There was a slight decrease in mild depression
over time, while severe depression increased (see Table 3).
However, these changes were statistically significant only
Fig. 1 12-month prevalence of MDD 1997–1999 (GHS-MHS: German National Health Interview and Examination Survey 1998, mental health
supplement, weighted for population structure as of 12/31/1997) vs. 2009–2012 (DEGS1-MH: German Health Interview and Examination Survey for
Adults, mental health module, weighted for population structure as of 12/31/2010). Age range: 18–65; p-values: Rao-Scott chi-square test for
testing differences between 1997–1999 and 2009–2012











Total, % (95%-CI) 4.9 (3.9–6.1) 4.2 (3.3–5.4) 0.363 10.0 (8.5–11.8) 10.5 (8.6–12.8) 0.728
Age group (years), % (95%-CI)
18–34 4.4 (3.0–6.5) 4.0 (2.4–6.7) 0.761 8.8 (6.6–11.6) 15.6 (11.3–21.0) 0.005
35–49 5.4 (3.9–7.5) 4.0 (2.4–6.7) 0.333 11.5 (9.2–14.3) 11.0 (8.1–14.7) 0.787
50–65 4.9 (3.4–6.9) 4.6 (3.1–6.8) 0.812 9.8 (7.3–13.0) 5.0 (3.5–7.1) 0.002
SES, % (95%-CI)
Low 5.6 (2.9–10.5) 5.1 (2.7–9.5) 0.864 11.7 (8.4–16.0) 17.0 (11.1–25.2) 0.128
Middle 5.3 (4.1–6.9) 4.4 (3.1–6.2) 0.331 10.1 (8.2–12.3) 9.3 (7.1–12.1) 0.610
High 3.3 (2.2–5.0) 3.1 (1.7–5.7) 0.874 8.6 (6.4–11.5) 8.6 (5.6–12.7) 0.981
1German National Health Interview and Examination Survey 1998, mental health supplement (GHS-MHS, 1997–1999): weighted for population structure as of 12/
31/1997; age range: 18–65
2German Health Interview and Examination Survey for Adults, mental health module (DEGS1-MH, 2009–2012): weighted for population structure as of 12/31/2010;
age range: 18–65
3p-value based on Rao-Scott chi-square test. Bold type indicates significant differences between 1997–1999 and 2009–2012 (local significance level α = 0.05)
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for women with mild depression, decreasing from 24.1%
to 13.8% (p = 0.045). Comparable results were obtained
when controlling for age in a multinomial logistic model
(results not shown). Furthermore, differences observed
were not attributable to changes only within specific age
groups (results not shown).
Prevalence of the nine depression symptoms in cases with
12-month MDD was heterogeneous (see Additional file 1).
Over time, there was a significant increase in the fre-
quency of reporting a feeling of guilt/worthlessness in
men (p = 0.035) and women (p = 0.019). In addition,
women reported significant weight/appetite change
more frequently in 2009–2012 (p < 0.001) and dimin-
ished interest/pleasure less frequently (p = 0.018).
Health-related correlates
Overall, men and women with 12-month MDD exhib-
ited worse outcomes for all health-related correlates
than participants without MDD at both time points (see
Table 4). Participants with 12-month MDD reported
fair/poor self-rated health significantly more often, had
significantly lower health-related quality of life in all
SF-36 sub-scales, and reported days with activity limita-
tion due to mental health problems and sick days more
frequently than participants without MDD.
The proportion of women with 12-month MDD report-
ing fair/poor self-rated health significantly decreased over
time from 40.4% to 21.3% (odds ratio [OR] = 0.4, p = 0.001,
see Table 5). This decrease was significantly more pro-
nounced among women with 12-month MDD (p = 0.043)
compared with the trend in women without MDD
(OR = 0.7). However, the trends converged when effect esti-
mates were adjusted for age (OR = 0.5 vs. OR= 0.7, p= 0.39,
see Additional file 2). For men with MDD, there was no sig-
nificant change in self-rated health over time (OR= 1.0) and
no significant divergence (p= 0.37) from the trend in men
without MDD (OR= 0.7).
Health-related quality of life (past 4 weeks) changed
over time: women with 12-month MDD showed a sig-
nificant improvement for the physical component by an
average of 3.8 points and a small but non-significant de-
terioration in the mental component (by −1.2 points),
when comparing participants between 1997–1999 and
2009–2012. These trends did not significantly differ
from female participants without MDD (p = 0.11 and
p = 0.87, respectively). For men with 12-month MDD,
there was no significant change over time in the
physical component (by −0.8 points), but also no sig-
nificant divergence (p = 0.25) from the improvement
observed in men without MDD. In contrast, aggrava-
tion of the mental component over time in men with
MDD (by −5.2 points) was significantly more pronounced
(p = 0.033) compared with men without MDD (see Fig. 2).
The outlined effect estimates for the total scales were
comparable when adjusted for age, except for minor dif-
ferences (see Additional file 2). The results for the total
scales reflect changes regarding the SF-36 sub-scales.
Women with 12-month MDD showed significant im-
provement in bodily pain over time (by 6.1 points). For all
sub-scales, time trends did not significantly differ between
women with and without MDD. In contrast, men showed
a slight aggravation over time on all SF-36 subscales,
reaching significance for social role functioning (by
−4.4 points) and emotional role functioning (by −8.3
points). These time trends among men with MDD
differed significantly from men without MDD in
emotional role functioning (p = 0.006) and bodily pain
(p = 0.030).
The risk of experiencing any days with activity limitation
(past 4 weeks) due to mental health problems was signifi-
cantly higher in 2009–2010 compared with 1997–1999 for
men and women, whether MDD was present or not (with
ORs ranging from 2.3 to 6.5). However, there was a trend
towards a more pronounced increase in women with
MDD compared with women without MDD (p = 0.056).
In contrast, the risk of experiencing days with activity
limitation due to physical health problems did not signifi-
cantly change over time. The proportion of days with
limitations due to physical health problems was already
significantly higher in 1997–1999 compared with











Depression severity, % (95%-CI)
Mild (5/9 symptoms) 31.7 (22.3–42.9) 27.1 (16.2–41.7) 0.574 24.1 (18.3–30.9) 13.8 (8.0–22.7) 0.045
Moderate (6 + 7/9 symptoms) 45.0 (35.2–55.1) 43.0 (31.0–55.9) 0.803 41.5 (34.2–49.2) 47.2 (37.0–57.7) 0.329
Severe (8 + 9/9 symptoms) 23.3 (15.8–33.1) 29.9 (19.0–43.7) 0.373 34.5 (27.2–42.6) 39.0 (28.2–51.1) 0.466
1German National Health Interview and Examination Survey 1998, mental health supplement (GHS-MHS, 1997–1999): weighted for population structure as of 12/
31/1997; age range: 18–65
2German Health Interview and Examination Survey for Adults, mental health module (DEGS1-MH, 2009–2012): weighted for population structure as of 12/31/2010;
age range: 18–65
3p-value based on Rao-Scott chi-square test. Bold type indicates significant differences between 1997–1999 and 2009–2012 (local significance level α = 0.05)
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limitation days due to mental health problems. In 2009–
2010, at least 25% of cases with 12-month MDD reported
some days involving limitations due to each type of
problem.
The risk of having any sick days (past 12 months)
slightly rose over time (with ORs ranging from 1.3–1.5),
but these changes were significant only for participants
without MDD. In 2009–2010, approximately 75% of
cases with 12-month MDD reported sick days. For
women with 12-month MDD reporting any sick days,
there was a trend towards a decreased number of sick
days over time, from an average of 39.6 days to 26.2 days
(incidence rate ratio 0.7, p = 0.089), but no change for
women without MDD. For men with depression, there
was no change over time in the number of sick days, but
also no significant divergence (p = 0.54) from the decline
in men without MDD (incidence ratio 0.8, p = 0.058, and




Based on nationally representative samples of the gen-
eral adult population, this study revealed no increase in
overall 12-month MDD prevalence in Germany over a
long period, irrespective of whether the data were stan-
dardized for demographic changes. Thus, the increased
depression frequencies in health insurance data and in-
creasing costs do not appear to reflect an “epidemic of
depression” on a population level. Overall, the current
results are in line with the initially presented
meta-analysis and findings of the Global Burden of
Disease Study, indicating no substantial change in MDD
prevalence between 1990 and 2010, or 2005 and 2015,
when adjusting for demographic changes [3, 7, 8]. How-
ever, women exhibited an MDD prevalence that was
twice as high in the youngest age-group and a decrease
in mild depression, corresponding to previous findings
of increasing depression prevalence or chronicity in
(younger) women [41–43].
Overall prevalence stability has previously been dis-
cussed as a potential outcome of improved prevention,
mental health care and treatment benefits over time,
possibly masking rising depression incidence or severity
of illness [17, 44]. Meanwhile, exposure to risk factors
for mental disorders in the population may have in-
creased (e.g., higher levels of stress due to growing social
inequality, isolation, urbanization and modernization in
general; [2, 3]). International findings of increased life-
time depression prevalence and chronicity in younger
cohorts appear to support this hypothesis [43, 45, 46].
However, societal changes could also result in reductions
of depression risks (e.g., improved education). Further-
more, a general decrease in psychological distress or psy-
chosocial stressors [47, 48], stable or even decreasing
depression incidence [41, 43, 44], unchanged episode
duration [44], and stable severity [49] have also been re-
ported. A recent review concluded that there is no sup-
port for the first hypothesis of increasing exposure to
risk factors in industrialized countries [17]. Likewise, po-
tential changes in sociodemographic correlates were
negligible for prevalence estimates in the current study,
even within population subgroups (e.g., age groups).
However, understanding the extent to which changes
Fig. 2 Health-related quality of life in 1997–1999 (GHS-MHS: German National Health Interview and Examination Survey 1998, mental health
supplement, weighted for population structure as of 12/31/1997. Age range: 18–65) vs. 2009–2012 (DEGS1-MH: German Health Interview and
Examination Survey for Adults, mental health module, weighted for population structure as of 12/31/2010. Age range: 18–65): Mental Component
Score (based on SF-36 and norm-based scoring)
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among women reflect growing exposure to risk factors
over time within this specific subgroup requires further
investigation.
Rising mental health care need?
Changes in health-related correlates revealed increased
disability over time in the MCS of SF-36, particularly
among men with MDD, and an increased risk of experi-
encing days with activity limitation due to mental health
problems. Thus, the current study provides some evi-
dence of an increased need for mental health care for
depression over time, particularly among men. Likewise,
national health insurance data documents increasing
work day loss attributable to depression (e.g. [50]), and
treatment-seeking rates for major depression have been re-
ported to be increasing internationally [51]. However, only
relatively small changes were observed in the current study,
and only slight improvement in non-help-seeking was re-
ported for participants with mental disorders between
1997–1999 and 2009–2012 (62% vs. 57%) in Germany [52].
Thus, increasing depression frequency in health insurance
data and growing costs cannot be explained solely by an in-
creased need for mental health care in depression.
However, changes in health-related correlates also oc-
curred in participants without MDD, while the percep-
tion of general health improved (see [37]). Likewise,
international findings also indicate increasing mental
health disability [53] and worsening of perceived mental
health status [47, 48]. Thus, declining mental wellbeing
may indicate an increasing need for mental health care
in general (e.g., due to rising psychosocial demands over
time). Another potential explanation is related to time
trends in the process of reporting depressive symptoms
themselves. The findings of several previous studies indi-
cate that increased mental health literacy in the general
population over time [54, 55] is associated with in-
creased (public) awareness, recognition of psychological
symptoms, and willingness to disclose [9, 11, 48, 56], as
well as elevated help-seeking behavior [57, 58]. Thus, in-
creased mental health literacy may have led to a more
negative evaluation of stressors and perceived mental
health over time, associated with rising subjective health
care needs. International findings have indicated such a
decrease in perceived mental health, while levels of dis-
tress were unchanged [47, 48, 53]. Having poor or fair
mental health literacy has even been reported to be pro-
tective against MDD [9]. Furthermore, several results
indicate age- and sex-dependent symptom expression
[59–61], and mental health literacy [9]. Thus, even find-
ings of increasing lifetime prevalence in younger cohorts
or rising depression prevalence among younger women
may be specifically associated with increased reporting of
symptoms. However, only minor changes in health-related
correlates were observed overall, and little evidence of
rising mental health literacy is available in view of the
enormous increases in national health insurance data (see
[17]).
Limitations
The following potential limitations should be considered
interpreting the findings of the current study. Underesti-
mation of MDD prevalence at both time points may
have been caused by “recall bias”, selective non-response
of less healthy participants and exclusion of institution-
alized individuals in both surveys [21, 22, 24]. Thus,
people with severe depression may have been particu-
larly underrepresented. In addition, participants’ “report-
ing bias” and varying diagnostic accuracy between
population subgroups may have led to prevalence under-
estimation in older participants and male participants
[62, 63]. Moreover, the inclusion of some longitudinal
data could lead to an underestimation of MDD preva-
lence in 2009–2012, due to a potentially higher rate of
re-participation among healthier participants. Moreover,
in the statistical analysis the two survey populations
were considered to be independent, neglecting potential
correlations related to re-participation of some partici-
pants in the DEGS1-MH. The particularly small number
of men with MDD in the surveys resulted in low statis-
tical power for detecting time trends within this sub-
group. A further potential limitation could be related to
the time lags between the core surveys and mental
health supplements, which may have led to an underesti-
mation of associations between 12-month MDD and
health-related correlates. However, associations may also
have been overestimated due to a construct overlap of
depressive symptoms (e.g., energy loss) with outcome
measures such as SF-36 and self-reported disability.
Conclusions
The current study provides valid, up-to-date information
about time trends in depression prevalence, severity and
symptoms in the general population in Germany over a
long period with a high-quality diagnostic level. To date,
national cross-sectional data has been lacking compar-
ability over time due to divergent measures or diagnostic
algorithms. Moreover, this is the first study comparing
DSM-IV-based major depression prevalence over time
while also considering health-related correlates. Further-
more, the current study also provides an evaluation of
time trends in view of demographic changes in the
underlying population. Thus, the current findings con-
tribute significantly to the ongoing national and inter-
national debate regarding the potential increase of
depression in western countries.
In contrast to the frequently claimed “epidemic” of de-
pression, we found stable overall prevalence in Germany
between 1997–1999 and 2009–2012. Demographic
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changes had a marginal impact on the examined time
trends within the considered age range. In conclusion,
increased depression frequencies in national health in-
surance data and associated growing health care costs
are not attributable to overall prevalence changes at a
population level.
However, shifted age distribution and increased severity
among women may reflect a rising depression risk within
this specific subgroup. Furthermore, we found some evi-
dence for an increased need for mental health care for de-
pression over time, particularly among men. However,
changes in mental wellbeing also occurred in the general
population, which may have also contributed to an increase
in depression diagnoses in the health care system. Thus,
the observed time trends suggest the need for further in-
vestigations of potentially rising psychosocial demands in
the general population, and specifically increasing depres-
sion risks among women, considering age- and sex-specific
developments in mental health literacy.
Finally, divergent time trends in primary and secondary
data indicate the need for a critical review of mental
health care in Germany, rising questions about the effects
of simultaneously expanded services and provision of
treatment (e.g. [64]). Jorm AF, Patten SB, Brugha TS and
Mojtabai R [17] already highlighted the impact of a “treat-
ment gap”, “quality gap” and “prevention gap” for the lack
of improvement in population prevalence. In Germany,
only 34.6% of participants with 12-month MDD reported
any service use due to mental health problems in 2009–
2012 [65]. Locally varying access to mental health care has
previously been identified as an important determinant of
help-seeking behavior [66, 67]. In addition, increasing ac-
ceptance of mental health care services [55] and rising
public knowledge appear to not have resulted in improved
social acceptance of people with mental illness over time
[54]. Furthermore, targeting of treatment seems to be
questionable: concordance of self-reported clinician diag-
nosed depression and DSM-IV-based MDD diagnosis is
remarkably low [33, 62]. False positive depression diagno-
ses were particularly high in primary care [68], also indi-
cating “over-representation” of depression within the
German health care system, concurrent with the persisting
treatment gap. Moreover, national health insurance data
provides evidence for lacking quality of treatment [69–73].
These findings suggest that public health initiatives in
Germany should continue to reduce access barriers to
mental health care services, and focus on improving tar-
geting and quality of treatment for depression. Further-
more, primary and secondary data seem to fundamentally
lack comparability with regard to their respective depres-
sion indicators. Thus, the current findings emphasize the
potential benefits of linking secondary data regarding
health care utilization and service provision with standard-
ized measures of depression based on primary data.
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